Arouche-Delaperche, L., Allenbach, Y., Amelin, D., Preusse, C., Mouly, V., Mauhin, W., Dzangue Tchoupou, G., Drouot, L., Boyer, O., Stenzel, W., Butler-Browne, G., Benveniste, O. :
Pathogenic role of anti-SRP and anti-HMGCR antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies
Ann Neurol, 2017 ; 81 (4) : 538-548
Publications (1184)
Schartner, V., Romero, N. B., Donkervoort, S., Treves, S., Munot, P., Pierson, T. M., Dabaj, I., Malfatti, E., Zaharieva, I. T., Zorzato, F., Abath Neto, O., Brochier, G., Lornage, X., Eymard, B., Taratuto, A. L., Bohm, J., Gonorazky, H., Ramos-Platt, L., Feng, L., Phadke, R., Bharucha-Goebel, D. X., Sumner, C. J., Bui, M. T., Lacene, E., Beuvin, M., Labasse, C., Dondaine, N., Schneider, R., Thompson, J., Boland, A., Deleuze, J. F., Matthews, E., Pakleza, A. N., Sewry, C. A., Biancalana, V., Quijano-Roy, S., Muntoni, F., Fardeau, M., Bonnemann, C. G., Laporte, J. :
Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy Acta Neuropathol, 2017 ; 133 (4) : 517-533
Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy Acta Neuropathol, 2017 ; 133 (4) : 517-533
Vilmont, V., Cadot, B., Ouanounou, G., Gomes, E. R. :
A system for studying mechanisms of neuromuscular junction development and maintenance Development, 2016 ; 143 (13) : 2464-77
A system for studying mechanisms of neuromuscular junction development and maintenance Development, 2016 ; 143 (13) : 2464-77
Musset, L., Allenbach, Y., Benveniste, O., Boyer, O., Bossuyt, X., Bentow, C., Phillips, J., Mammen, A., Van Damme, P., Westhovens, R., Ghirardello, A., Doria, A., Choi, M. E., Fritzler, M. J., Schmeling, H., Muro, Y., La Torre, I. G., Ortiz-Villalvazo, M. A., Bizzaro, N., Infantino, M., Imbastaro, T., Peng,, Wang, G., Vencovsky, J., Klein, M., Krystufkova, O., Franceschini, F., Fredi, M., Hue, S., Belmondo, T., Danko, K., Mahler, M. :
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study Autoimmun Rev, 2016 ; (SP) :
Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study Autoimmun Rev, 2016 ; (SP) :
Polesskaya, A., Pinna, G., Sassi, Y., Vandamme, M., Bigot, A., Mouly, V., Morozova, N., Harel-Bellan, A., Degerny, C. :
Post-transcriptional modulation of interleukin 8 by CNOT6L regulates skeletal muscle differentiation Biochim Biophys Acta, 2016 ; 1863 (2) : 263-70
Post-transcriptional modulation of interleukin 8 by CNOT6L regulates skeletal muscle differentiation Biochim Biophys Acta, 2016 ; 1863 (2) : 263-70
Dragin, N., Bismuth, J., Cizeron-Clairac, G., Biferi, M. G., Berthault, C., Serraf, A., Nottin, R., Klatzmann, D., Cumano, A., Barkats, M., Le Panse, R., Berrih-Aknin, S. :
Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases J Clin Invest, 2016 ; 126 (4) : 1525-37
Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases J Clin Invest, 2016 ; 126 (4) : 1525-37
Cea, L. A., Bevilacqua, J. A., Arriagada, C., Cardenas, A. M., Bigot, A., Mouly, V., Saez, J. C., Caviedes, P. :
The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes BMC Cell Biol, 2016 ; 17 Suppl 1 : 15
The absence of dysferlin induces the expression of functional connexin-based hemichannels in human myotubes BMC Cell Biol, 2016 ; 17 Suppl 1 : 15
Ricotti, V., Evans, M. R., Sinclair, C. D., Butler, J. W., Ridout, D. A., Hogrel, J. Y., Emira, A., Morrow, J. M., Reilly, M. M., Hanna, M. G., Janiczek, R. L., Matthews, P. M., Yousry, T. A., Muntoni, F., Thornton, J. S. :
Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials PLoS ONE, 2016 ; 11 (9) : e0162542
Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials PLoS ONE, 2016 ; 11 (9) : e0162542
Malfatti, E., Barnerias, C., Hedberg-Oldfors, C., Gitiaux, C., Benezit, A., Oldfors, A., Carlier, R. Y., Quijano-Roy, S., Romero, N. B. :
A novel neuromuscular form of glycogen storage disease type IV with arthrogryposis, spinal stiffness and rare polyglucosan bodies in muscle Neuromuscul Disord, 2016 ; 26 (10) : 681-687
A novel neuromuscular form of glycogen storage disease type IV with arthrogryposis, spinal stiffness and rare polyglucosan bodies in muscle Neuromuscul Disord, 2016 ; 26 (10) : 681-687
Allenbach, Y., Leroux, G., Suarez-Calvet, X., Preusse, C., Gallardo, E., Hervier, B., Rigolet, A., Hie, M., Pehl, D., Limal, N., Hufnagl, P., Zerbe, N., Meyer, A., Aouizerate, J., Uzunhan, Y., Maisonobe, T., Goebel, H. H., Benveniste, O., Stenzel, W., French Myositis, Network :
Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression Am J Pathol, 2016 ; 186 (3) : 691-700
Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: Common Interferon Signature but Distinct NOS2 Expression Am J Pathol, 2016 ; 186 (3) : 691-700
